Loading company
Integra Lifesciences Holdings Corp.
IART · Nasdaq · ·
Next earnings: October 29, 2026
$16.65+2.5%Sep 29 close
- 1M
- -1.4%
- 6M
- +82.6%
- 1Y
- +16.2%
- 5Y
- -76.8%
IART · Nasdaq · ·
Next earnings: October 29, 2026
$16.65+2.5%Sep 29 close
Integra Lifesciences Holdings Corp. is scheduled to report next on October 29, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $418.8M | $415.6M | +0.76% |
| Profit | $4.5M | -$484.1M | +100.93% |
| Profit per share | $0.06 | -$6.31 | +100.95% |
| Free Cash Flow | $10.5M | -$11.2M | +193.48% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“Our second-quarter performance reflects meaningful progress on our most important priorities. We are improving supply reliability, advancing quality, and returning products to market with discipline. The Braintree facility is now producing and ramping to support the planned SurgiMend relaunch later this year,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies are trusted by healthcare professionals to deliver life-saving care. For our latest news and information, visit www.integralife.com.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Integra Lifesciences Holdings Corp.’s Item 2.02 8-K filed July 29, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Integra Lifesciences Holdings Corp. has no earnings call transcript available.